Search

everythinglearnresearchcommunity

for

Search:↓

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Removing an adrenal tumor can significantly reduce high androgen levels in postmenopausal women.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

A woman's severe hirsutism was caused by Leydig cell tumors in her ovaries, which improved after surgery.

A rare ovarian tumor caused high male hormone levels, but surgery fixed it.

Nafarelin may effectively treat excessive hair growth in women by reducing certain hormone levels.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

A postmenopausal woman with hair loss and hirsutism improved after surgery to remove an ovarian tumor.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.

Rare ovarian tumors can cause increased male hormones in postmenopausal women; surgery is an effective treatment.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

A 13-year-old girl's masculine symptoms improved after surgery for a rare adrenal tumor that produced male hormones.

Understanding gender differences and individual patient characteristics is essential for optimal cosmetic surgery outcomes.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Finasteride reduces prostate size and DHT in male mastomys but not in females.

Ovarian steroid cell tumors should be considered in adults with hirsutism and high testosterone, with surgery as the main treatment.

Gender-affirming hormone therapy in South Korea aligns with international guidelines and has specific side effects.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Gastric bypass surgery improved a woman's hormonal disorder without the need for medication.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

Thorough evaluation is crucial for postmenopausal women with virilization to detect rare ovarian tumors.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

A 68-year-old woman developed male traits due to a tumor in her ovary, which was removed, returning her hormone levels to normal.

A woman had high testosterone due to an ovarian issue, which was fixed with surgery.

A 10-year-old girl's symptoms improved after surgery to remove a benign adrenal tumor.

A postmenopausal woman's masculine symptoms improved after surgery for a hormone-producing ovarian tumor.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.